Lupin Receives US FDA Approval For Amlodipine Capsules (08-Feb-2010)
Pharma major, Lupin Ltd announced today that the US Food and Drug Administration (US FDA) has granted final approval for its Amlodipine/Benazepril 2,5mg/10mg, 5mg/10mg, 5mg/20ing and 10nig/2()mg capsules. Commercial shipments of the product have already commenced.
Lupin''s Amlodipine/Benazepril capsules are the AB-rated generic equivalent of Novartis'' I/jtrel® capsules indicated for the treatment of hypertension. Amlodipine/Benazcpril had annual sales of approximately $1.1 billion for the twelve months ended September 2009, based on IMS Health sales data.
Commenting on the approval, Nflesh Gupta, Group President and Executive DirecLor of Lupin Limited, said, "We are very pleased with the approval of our Amlodipine/Benazepril capsules, ITiis is a significant approval and it broadens our growing portfolio of cardiovascular medications with a strong complement to our existing product line." Mr, Gupta added, "The approval reflects the confidence and acceptance of our facility by die FDA, as well as our unwavering commitment to quality'' and to bringing important products to market."
Top News Today
 Mahindra Satyam, the brand identity of Satyam Computer Services has developed an integrated migration solutions for healthcare payer organizations that would meet the new federal and Health Insurance Portability
 Private sector air carrier, Kingfisher Airlines, has decided to mop-up fresh funds of up to Rs 5,000 crore through issue of various instruments including preference shares, equity shares, Global Depository
 The government is expected to take decision on exportable quantity of cotton this week. The move follows recent lifting of the export ban on the cotton which was imposed earlier this year to restrict spiraling
|
Live Market Discussions With Site Visitors
|
|
|